Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:


Last Updated: January 25, 2020

DrugPatentWatch Database Preview

Twi Pharms Company Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the competitive landscape for TWI PHARMS, and what generic and branded alternatives to TWI PHARMS drugs are available?

TWI PHARMS has seventeen approved drugs.

There are two tentative approvals on TWI PHARMS drugs.

Summary for Twi Pharms
US Patents:0

Drugs and US Patents for Twi Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Twi Pharms Inc CYCLOBENZAPRINE HYDROCHLORIDE cyclobenzaprine hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 091281-002 Jan 31, 2013 AB RX No No   Start Trial   Start Trial
Twi Pharms DILTIAZEM HYDROCHLORIDE diltiazem hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 205231-003 Aug 30, 2018 AB3 RX No No   Start Trial   Start Trial
Twi Pharms BUPROPION HYDROCHLORIDE bupropion hydrochloride TABLET, EXTENDED RELEASE;ORAL 210081-001 Nov 3, 2017 AB3 RX No No   Start Trial   Start Trial
Twi Pharms METOPROLOL SUCCINATE metoprolol succinate TABLET, EXTENDED RELEASE;ORAL 207206-003 Dec 19, 2018 AB RX No No   Start Trial   Start Trial
Twi Pharms FENOFIBRIC ACID choline fenofibrate CAPSULE, DELAYED RELEASE;ORAL 210469-001 Jul 5, 2019 AB RX No No   Start Trial   Start Trial
Twi Pharms NIFEDIPINE nifedipine TABLET, EXTENDED RELEASE;ORAL 203126-002 Apr 3, 2014 AB2 RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.